INDIANAPOLIS, May 31, 2024 (GLOBE NEWSWIRE) -- The Mark Cuban Foundation, in collaboration with Corteva, is bringing the only artificial intelligence (AI) camp of its kind, free of charge, to high school students in Indianapolis. The camp offers a custom and highly relevant curriculum focused on teaching students about the latest developments in the world of AI, and it will educate, inspire and fuel the next generation of innovators. These AI bootcamps are introductory and accessible to students in grades 9 ...

业绩展望 - Corteva预计2024年EBITDA范围为35亿至37亿美元，中间值为36亿美元[8] - 预计2024年上半年EBITDA将略低于2023年实际水平[10] - 预计2024年第一季度种子定价整体上涨6%，玉米表现更强，豆类方面竞争更激烈，预计上半年定价将达到4%至5%左右[46] 新产品和技术研发 - Corteva在2024年将推出超过300种新的种子杂交品种和品种[4] - Corteva预计2024年第二季度将有约150种新产品和配方推出[22] - Conkesta是公司在巴西重新建立大豆品牌的第一步，表现良好，正在逐步增加品种[91] 市场扩张和并购 - 公司预计明年种植面积将增加，预计将恢复到前一年78%的减少[90] - 欧洲对基因编辑规则放宽，公司计划在11月份的投资者活动中详细介绍基因编辑的机会[98] - 公司加速投资，在管道中推出了产量产品和疾病控制产品，全球各地都看到了积极的动力[100]

INDIANAPOLIS, May 8, 2024 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announces that Executive Vice President and Chief Financial Officer, Dave Anderson, and Executive Vice President and Chief Technology and Digital Officer, Sam Eathington, will speak at the 2024 BMO Farm to Market Chemicals Conference at 9:30 a.m. Eastern Time on Wednesday, May 15, 2024. Remarks will be webcast live. Registration for the webcast can be accessed through the Corteva Investor Relations website. A replay of the presentation wil ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ☒EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ☐EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number 001-38710 Corteva, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 82-4979096 (S ...

财务数据和关键指标变化 - 第一季度收入下降6%,其中种子业务收入增长5%,作物保护业务收入下降20% [24][25] - 第一季度EBITDA下降16%,EBITDA利润率下降约200个基点 [26] - 公司预计全年EBITDA将在35-37亿美元区间,保持前期指引不变 [11][37] 各条业务线数据和关键指标变化 种子业务 - 种子业务第一季度收入增长2%,有机销售增长5%,价格上涨6% [27] - 种子订单反映出强劲需求,公司计划今年推出约300款新种子品种 [13][14] - 预计种子业务在上半年将保持良好势头,下半年可能出现小幅亏损 [32][34] 作物保护业务 - 作物保护业务第一季度收入下降20%,销量下降18% [28] - 价格下降3%,主要受到竞争压力和渠道库存管理紧缩的影响 [28] - 预计下半年作物保护业务将恢复增长,生物制品和新产品带动销量提升 [35] - 公司正在优化全球作物保护资产布局,预计到2025年可实现年度成本节约1亿美元 [20] 各个市场数据和关键指标变化 - 北美市场种子业务表现良好,但其他地区种子销量下滑 [25][27] - 欧洲和拉美地区作物保护业务受到去库存影响,北美地区受到购买时间推迟的影响 [25][28] - 预计下半年拉美市场作物保护业务将恢复增长,生物制品业务在巴西的强势地位将带动增长 [35] 公司战略和发展方向及行业竞争 - 公司正在从净技术购买者转变为净技术销售者,Enlist等自有技术正在快速推广 [71][72] - 公司将持续推出新产品,并通过提价获取价值,预计未来几年种子价格将保持低个位数增长 [73][74] - 作物保护业务正在通过退出低毛利产品、推出生物制品等措施提升盈利能力 [18][20] - 公司预计行业将在2025年恢复增长,自身也将受益于成本下降和新产品带来的增长 [126][127] 管理层对经营环境和未来前景的评论 - 农业大宗商品需求依然强劲,农民收益水平总体健康,为公司业务发展提供良好环境 [10][11] - 公司正在通过提价、成本优化等措施应对当前竞争环境,有信心实现全年业绩指引 [11][20] - 对2025年的财务目标框架保持信心,相信未来几年公司将受益于新技术推广、成本下降等因素 [139][140][141] 问答环节重要的提问和回答 问题1 **Vincent Andrews 提问** 询问公司对第二季度业绩的信心和可见度 [47] **Chuck Magro 和 Dave Anderson 回答** - 农业大宗商品需求依然强劲,为公司业务发展提供良好环境 [48][49] - 种子业务在北美表现强劲,为上半年业绩提供支撑 [51][52][53] - 作物保护业务在第二季度和下半年将逐步改善,成本优化措施也将发挥作用 [54][55][56][57] 问题2 **Joel Jackson 提问** 询问公司对dicamba除草剂未来的看法及其对种子业务策略的影响 [67] **Tim Glenn 回答** - 2024年dicamba对种子销售影响有限,但2025年存在较大不确定性 [78][79][80] - 公司已为不同情况做好准备,包括增加Enlist等替代技术的种子供给 [83][84][85] 问题3 **Chris Parkinson 提问** 询问公司对2024年和2025年种子及作物保护业务成本的预期 [109] **Dave Anderson 回答** - 2024年种子业务成本有所上升,主要是由于巴西safrinha玉米产量恢复带来的成本压力 [110][111] - 2024年作物保护业务将受益于原材料价格下降,预计下半年成本下降1亿美元 [112][113][114] - 上述成本变化趋势将为2025年业绩改善奠定基础 [115]

1Q 2024 Earnings Conference Call May 2, 2024 Safe Harbor Regarding Forward-Looking Statements Forward-Looking Statements This presentation contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may b ...

Corteva, Inc. (CTVA) reported $4.49 billion in revenue for the quarter ended March 2024, representing a year- over-year decline of 8%. EPS of $0.89 for the same period compares to $1.16 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $4.56 billion, representing a surprise of -1.42%. The company delivered an EPS surprise of +12.66%, with the consensus EPS estimate being $0.79. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall St ...

A-1 Corteva, Inc. Consolidated Statements of Operations (Dollars in millions, except per share amounts) Three Months Ended March 31, 2024 2023 Net sales $ 4,492 $ 4,884 Cost of goods sold 2,550 2,771 Research and development expense 332 316 Selling, general and administrative expenses 736 726 Amortization of intangibles 177 160 Restructuring and asset related charges - net 75 33 Other income (expense) - net (99) (71) Interest expense 41 31 Income (loss) from continuing operations before income taxes 482 776 ...

1Q results in line with expectations and mostly constructive ag economy Strength of Seed performance demonstrates global demand for top technology Crop Protection declines reflect just-in-time purchases and residual inventory imbalances FY guidance unchanged, 2024 outlook supported by controllable levers INDIANAPOLIS, May 1, 2024 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the three months ended March 31, 2024. 1Q 2024 Results Overview Net Sal ...

Analysts on Wall Street project that Corteva, Inc. (CTVA) will announce quarterly earnings of $0.79 per share in its forthcoming report, representing a decline of 31.9% year over year. Revenues are projected to reach $4.56 billion, declining 6.7% from the same quarter last year. Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 3.7% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this perio ...